A Canadian manufacturer of positron emission tomography equipment has received FDA’s OK to market a small-footprint scanner that images targeted organs bearing radiotracers at close range.

A global tech and pharma vendor is set to inject U.S. healthcare with a set of generic contrast agents, the first of which will be an FDA-approved substitute for GE Healthcare’s Visipaque.

Eric Williamson, MD, MSCCT, the 2021-2022 president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, shared his key takeaways from the SCCT 2022 conference. 

In the largest known study to date on the relationship between moderate alcohol consumption and iron homeostasis, experts suggested that as little as four drinks per week can increase the presence of iron deposits on imaging.

On July 18 Fresenius Kabi announced that they are rolling out a line of generic contrast media products, starting immediately with Iodixanol Injection USP. 

In countries with low to middling gross national incomes, screening mammography appears to be a cost-effective means of minimizing breast cancer’s economic costs and public-health burdens at the population level. However …

The model was externally validated using more than 1,500 radiographs with real-world incidence of critically misplaced tubes. 

Citing low health literacy as a barrier between providers and patients in overcoming healthcare disparities, DenseBreast-info.org updated their breast density materials to include more patient-friendly, “simple language.”